Literature DB >> 22922563

Comparing hippocampal atrophy in Alzheimer's dementia and dementia with lewy bodies.

Nicole Chow1, Dag Aarsland, Hedieh Honarpisheh, Mona K Beyer, Johanne H Somme, David Elashoff, Arvid Rongve, Ole B Tysnes, Paul M Thompson, Liana G Apostolova.   

Abstract

BACKGROUND/AIMS: Dementia with Lewy bodies (DLB) and Alzheimer's disease (AD) are the two most common neurodegenerative dementias. During the early stages, clinical distinction between them is often challenging. Our objective is to compare hippocampal atrophy patterns in mild AD and mild DLB. We hypothesized that DLB subjects have milder hippocampal atrophy relative to AD subjects.
METHODS: We analyzed the T1-weighted magnetic resonance imaging data from 113 subjects: 55 AD, 16 DLB and 42 cognitively normal elderly (normal controls, NC). Using the hippocampal radial distance technique and multiple linear regression, we analyzed the effect of clinical diagnosis on hippocampal radial distance, while adjusting for gender and age. Three-dimensional statistical maps were adjusted for multiple comparisons using permutation-based statistics with a threshold of p < 0.01.
RESULTS: Compared to NC, AD exhibited significantly greater atrophy in the cornu ammonis (CA)1, CA2-3 and subicular regions bilaterally while DLB showed left-predominant atrophy in the CA1 region and subiculum. Compared directly, AD and DLB did not reveal statistically significant differences.
CONCLUSION: Hippocampal atrophy, while present in mildly impaired DLB subjects, is less severe than atrophy seen in mildly impaired AD subjects, when compared to NC. Both groups show predominant atrophy of the CA1 subfield and subiculum.
Copyright © 2012 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2012        PMID: 22922563      PMCID: PMC3470878          DOI: 10.1159/000339727

Source DB:  PubMed          Journal:  Dement Geriatr Cogn Disord        ISSN: 1420-8008            Impact factor:   2.959


  38 in total

1.  A twin study of genetic contributions to hippocampal morphology in schizophrenia.

Authors:  Katherine L Narr; Theo G M van Erp; Tyrone D Cannon; Roger P Woods; Paul M Thompson; Seonah Jang; Rebecca Blanton; Veli-Pekka Poutanen; Matti Huttunen; Jouko Lönnqvist; Carl-Gustav Standerksjöld-Nordenstam; Jaakko Kaprio; John C Mazziotta; Arthur W Toga
Journal:  Neurobiol Dis       Date:  2002-10       Impact factor: 5.996

2.  A comparison of medial and lateral temporal lobe atrophy in dementia with Lewy bodies and Alzheimer's disease: magnetic resonance imaging volumetric study.

Authors:  R Barber; I G McKeith; C Ballard; A Gholkar; J T O'Brien
Journal:  Dement Geriatr Cogn Disord       Date:  2001 May-Jun       Impact factor: 2.959

3.  Alzheimer's disease, Lewy body disease and aging: a comparative study of the perforant pathway.

Authors:  C F Lippa; D Pulaski-Salo; D W Dickson; T W Smith
Journal:  J Neurol Sci       Date:  1997-04-15       Impact factor: 3.181

4.  Clinical predictors of improvement after electroconvulsive therapy of patients with schizophrenia, neurotic reactions, and affective disorders.

Authors:  M Folstein; S Folstein; P R McHugh
Journal:  Biol Psychiatry       Date:  1973-10       Impact factor: 13.382

5.  Diagnostic accuracy of dementia with Lewy bodies.

Authors:  U Hohl; P Tiraboschi; L A Hansen; L J Thal; J Corey-Bloom
Journal:  Arch Neurol       Date:  2000-03

6.  Unbiased stereological estimation of the number of neurons in the human hippocampus.

Authors:  M J West; H J Gundersen
Journal:  J Comp Neurol       Date:  1990-06-01       Impact factor: 3.215

7.  Comparing gray matter loss profiles between dementia with Lewy bodies and Alzheimer's disease using cortical pattern matching: diagnosis and gender effects.

Authors:  Martina Ballmaier; John T O'Brien; Emma J Burton; Paul M Thompson; David E Rex; Katherine L Narr; Ian G McKeith; Heather DeLuca; Arthur W Toga
Journal:  Neuroimage       Date:  2004-09       Impact factor: 6.556

8.  Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease.

Authors:  G McKhann; D Drachman; M Folstein; R Katzman; D Price; E M Stadlan
Journal:  Neurology       Date:  1984-07       Impact factor: 9.910

9.  Mapping hippocampal and ventricular change in Alzheimer disease.

Authors:  Paul M Thompson; Kiralee M Hayashi; Greig I De Zubicaray; Andrew L Janke; Stephen E Rose; James Semple; Michael S Hong; David H Herman; David Gravano; David M Doddrell; Arthur W Toga
Journal:  Neuroimage       Date:  2004-08       Impact factor: 6.556

10.  Influence of Alzheimer pathology on clinical diagnostic accuracy in dementia with Lewy bodies.

Authors:  A R Merdes; L A Hansen; D V Jeste; D Galasko; C R Hofstetter; G J Ho; L J Thal; J Corey-Bloom
Journal:  Neurology       Date:  2003-05-27       Impact factor: 9.910

View more
  15 in total

1.  Differential Atrophy in the Hippocampal Subfield Volumes in Four Types of Mild Dementia.

Authors:  Lin Huang; Keliang Chen; Xiaochen Hu; Qihao Guo
Journal:  Front Neurosci       Date:  2020-07-09       Impact factor: 4.677

Review 2.  Role of Neuroimaging on Differentiation of Parkinson's Disease and Its Related Diseases.

Authors:  Toshihide Ogawa; Shinya Fujii; Keita Kuya; Shin-Ichiro Kitao; Yuki Shinohara; Mana Ishibashi; Yoshio Tanabe
Journal:  Yonago Acta Med       Date:  2018-09-26       Impact factor: 1.641

3.  Synergistic and additive effects of enriched environment and lithium on the generation of new cells in adult mouse hippocampus.

Authors:  Evelin L Schaeffer; Fabiana G Cerulli; Hélio O X Souza; Sergio Catanozi; Wagner F Gattaz
Journal:  J Neural Transm (Vienna)       Date:  2014-02-20       Impact factor: 3.575

4.  In vivo hippocampal subfield shape related to TDP-43, amyloid beta, and tau pathologies.

Authors:  Veronika Hanko; Alexandra C Apple; Kathryn I Alpert; Kristen N Warren; Julie A Schneider; Konstantinos Arfanakis; David A Bennett; Lei Wang
Journal:  Neurobiol Aging       Date:  2018-10-25       Impact factor: 4.673

5.  Atrophy of the cholinergic basal forebrain in dementia with Lewy bodies and Alzheimer's disease dementia.

Authors:  Michel J Grothe; Christina Schuster; Florian Bauer; Helmut Heinsen; Johannes Prudlo; Stefan J Teipel
Journal:  J Neurol       Date:  2014-07-25       Impact factor: 4.849

Review 6.  Differentiating dementia with Lewy bodies from Alzheimer's disease and Parkinson's disease dementia: an update on imaging modalities.

Authors:  Rotem Iris Orad; Tamara Shiner
Journal:  J Neurol       Date:  2021-01-29       Impact factor: 4.849

Review 7.  Non-Alzheimer's disease-related memory impairment and dementia.

Authors:  Sönke Arlt
Journal:  Dialogues Clin Neurosci       Date:  2013-12       Impact factor: 5.986

8.  Multi-modal MRI investigation of volumetric and microstructural changes in the hippocampus and its subfields in mild cognitive impairment, Alzheimer's disease, and dementia with Lewy bodies.

Authors:  Elijah Mak; Silvy Gabel; Li Su; Guy B Williams; Robert Arnold; Luca Passamonti; Patricia Vazquez Rodríguez; Ajenthan Surendranathan; W Richard Bevan-Jones; James B Rowe; John T O'Brien
Journal:  Int Psychogeriatr       Date:  2017-01-16       Impact factor: 3.878

Review 9.  Neuroimaging characteristics of dementia with Lewy bodies.

Authors:  Elijah Mak; Li Su; Guy B Williams; John T O'Brien
Journal:  Alzheimers Res Ther       Date:  2014-04-09       Impact factor: 6.982

10.  Ser46-Phosphorylated MARCKS Is a Marker of Neurite Degeneration at the Pre-aggregation Stage in PD/DLB Pathology.

Authors:  Kyota Fujita; Hidenori Homma; Kanoh Kondo; Masashi Ikuno; Hodaka Yamakado; Kazuhiko Tagawa; Shigeo Murayama; Ryosuke Takahashi; Hitoshi Okazawa
Journal:  eNeuro       Date:  2018-09-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.